Our Experience of Nutraceutical Effects in Age-Related Macular Degeneration
Purpose: to assess the possibilities of ophthalmonutraceuticals using in age-related macular degeneration (AND) patients.Patients Methods. The study included 35 patients (68.3 ± 6.3 years old; 15 men, 20 women) with AMD (AREDS-2 and AREDS-3 categories). As an ophthalmic nutraceutical, a biological a...
Saved in:
Main Authors: | S. V. Yanchenko, A. V. Malyshev, S. N. Sakhnov, A. S. Balayan, A. A. Sergienko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ophthalmology Publishing Group
2020-12-01
|
Series: | Oftalʹmologiâ |
Subjects: | |
Online Access: | https://www.ophthalmojournal.com/opht/article/view/1378 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of Nutraceutical Support in Age-Related Macular Degeneration Patients
by: S. V. Yanchenko, et al.
Published: (2023-01-01) -
The Use of Nutraceuticals in Patients with “Dry” Form of Age-Related Macular Degeneration on the Background of Accelerated Aging
by: S. A. Korotkih, et al.
Published: (2019-06-01) -
Lutein-Containing Antioxidants in Patients with Primary Open-Angle Glaucoma and Dry Type of Age-Related Macular Degeneration
by: D. A. Dorofeev
Published: (2018-10-01) -
Changes in Macular Pigment Optical Density as a New Risk Factor for Primary Open-angle Glaucoma
by: I. A. Loskutov, et al.
Published: (2025-06-01) -
Nutraceuticals for Age-Related Macular Degeneration: Formulation Optimization Focused on Safety
by: E. K. Pedanova
Published: (2022-04-01)